Yiming Chen

Mr. Yiming Chen

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2023 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
YCYiming Chen
Yiming Chen
HZHuimin Zhang
Huimin Zhang
WNWenwen Ning
Wenwen Ning
YCYijie Chen
Yijie Chen
CWCaihe Wen
Caihe Wen
Background: This study analyzed the pregnancy outcomes of patients with intrahepatic cholestasis of pregnancy (ICP) in Hangzhou, China.Methods: Cases of pregnant women monitored by antepartum testing at Hangzhou Women’s Hospital from January 2018 to December 2020 were reviewed. Subjects were classified into two groups according to whether they had ICP: 688 cases of ICP were assigned to an exposure group while 38,556 cases of non-ICP were assigned to a non-exposed group. Univariate analysis was performed on qualitative or quantitative data using the Chi-Squared test or Mann–WhitneyUtest, and the adjusted odds ratio (aOR) and 95% confidence interval (CI) of the two groups of related variables were calculated by multivariate binary logistic regression analysis.Results: The incidence rate of ICP was 1.75%. Pregnant women with hepatitis B virus were correlated with ICP. Hepatitis B carriers (aOR = 3.873), preeclampsia (PE, aOR = 3.712), thrombocytopenia (aOR = 1.992), gestational hypertension (GH, aOR = 1.627), hyperlipidemia (aOR = 1.602) and gestational diabetes mellitus (GDM, aOR = 1.265) were all risk factors for ICP. In contrast, Body Mass Index (BMI) ≥ 30 kg/m2(aOR = 0.446), 25 m2< maternal BMI < 29.9 kg/m2(aOR = 0.699) and parity ≥ 1 (aOR = 0.722) were protective factors for ICP. Pregnant women in the ICP group had an increased risk of gestation days < 259 days (aOR = 4.574) and cesarean delivery (aOR = 1.930) after ICP, and a decreased risk of longer gestational days (aOR = 0.105), premature rupture of membranes (aOR = 0.384) and fetal macrosomia (aOR = 0.551).Conclusions: By analyzing a Chinese population with ICP, we identified that pregnant women who are hepatitis B carriers or with PE, thrombocytopenia, GH, hyperlipidemia, and GDM are at higher risk of ICP. Moreover, ICP is associated with adverse pregnancy outcomes; in particular, ICP may increase the incidence of shorter gestational days and non-vaginal delivery methods such as cesarean section but reduce the incidence of premature rupture of membranes and fetal macrosomia.

19 June 2020 in EPMA Journal
Verified
Journal Article
Closed access
PDF file
YCYiming Chen
Yiming Chen
ZXZhen Xie
Zhen Xie
XWXue Wang
Xue Wang
QXQingxin Xiao
Qingxin Xiao
XLXiao Lu
Xiao Lu
SLShaolei Lv
Shaolei Lv

1 August 2020 in Clinica Chimica Acta
Verified
Journal Article
Closed access
YCYiming Chen
Yiming Chen
XWXue Wang
Xue Wang
SLSha Lu
Sha Lu
JHJianxia Huang
Jianxia Huang
LZLidan Zhang
Lidan Zhang
WHWensheng Hu
Wensheng Hu

20 April 2022 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
YCYiming Chen
Yiming Chen
WNWenwen Ning
Wenwen Ning
XWXue Wang
Xue Wang
YCYijie Chen
Yijie Chen
BWBin Wu
Bin Wu
JTJie Tao
Jie Tao
To investigate the effect of maternal hepatitis B surface antigen (HBsAg) carrier status during pregnancy on pregnancy outcomes in a population of patients in Hangzhou, China. A retrospective cohort study was conducted to analyse data from 20 753 pregnant women who delivered at Hangzhou Women's Hospital between January 2015 and March 2020. Of these, 18 693 were normal pregnant women (the non-exposed group) and 735 were HBsAg carriers (the exposed group). We then analysed by binary multivariate logistic regression to determine the association between maternal HBsAg-positive and adverse pregnancy outcomes. The prevalence of HBsAg carriers was 3.78% and the odds ratio (OR) for maternal age in the exposed group was 1.081. Pregnant women who are HBsAg-positive in Hangzhou, China, are at higher risk of a range of adverse pregnancy outcomes, including intrahepatic cholestasis of pregnancy (ICP) (adjusted OR (aOR) 3.169), low birth weight (aOR 2.337), thrombocytopenia (aOR 2.226), fallopian cysts (aOR 1.610), caesarean scar pregnancy (aOR 1.283), foetal distress (aOR 1.414). Therefore, the obstetricians should pay particular attention to ICP, low birth weight, thrombocytopenia, fallopian cysts, caesarean scar, foetal distress in HBsAg-positive pregnant women.

14 December 2020 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
YCYiming Chen
Yiming Chen
XWXue Wang
Xue Wang
LLLiyao Li
Liyao Li
SLSha Lu
Sha Lu
ZZZhifen Zhang:
Zhifen Zhang:
Background: To determine whether advanced maternal age (AMA) causes changes in the maternal serum markers of Trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester of pregnancy. Our research aims to develop new cut-off values for AMA in order to reduce the need for further invasive testing.Methods: This retrospective cohort study involved 12,739 pregnant women with AMA and 197,101 pregnant women with non-AMA. We then compared the two groups with respect to the positive rate and positive predictive value (PPV) of Trisomy 21, 18 and ONTD. Pregnant women with Trisomy 21, 18 and ONTD were diagnosed by karyotyping the amniotic fluid and by ultrasound diagnosis.Results: Compared to the non-AMA group, the multiple of the median (MOM) of free beta- human chorionic gonadotropin (free β-hCG), alpha-fetoprotein (AFP), and the risk value forTrisomy 21, were significantly higher in the AMA group (allP < 0.001). The positive rates of Trisomy 21, 18, and ONTD in the AMA group were significantly higher than those in the control group (allP < 0.001). In the AMA group, the PPVs for Trisomy 21 and other deformities were significantly higher (allP < 0.001), although the PPVs for Trisomy 18 and ONTD were similar to those of the non-AMA group. The area under the curve (AUC) values for the AMA group were higher than the non-AMA group, based on free β-hCG MoM, AFP MoM, and the risk value of Trisomy 21. The cut-off value for the risk value of Trisomy 21 was 1/172 for the AMA, group and 1/780 for the non-AMA group.Conclusions: The positive rates for Trisomy 21, 18 and ONTD, and the PPV for Trisomy 21 and other deformities were significantly higher in the AMA group. It is essential for pregnant women with AMA to be tested using appropriate cut-off values of serum markers screening for Trisomy 21 during the second trimester of pregnancy to improve the efficacy of prenatal screening and reduce the need for further invasive testing.

27 February 2023 in Clinical and Experimental Hypertension
Verified
Journal Article
Open access
XDXiaoqing Dai
Xiaoqing Dai
HZHuimin Zhang
Huimin Zhang
BWBin Wu
Bin Wu
WNWenwen Ning
Wenwen Ning
YCYijie Chen
Yijie Chen
YCYiming Chen
Yiming Chen
To evaluate the correlation between elevated maternal serum alpha-fetoprotein (AFP) in the second trimester and ischemic placental disease (IPD).A retrospective cohort study was conducted to analyz...